Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant homodimer of the human annexin V

EU orphan designation number: EU/3/11/946
Active ingredient: Recombinant homodimer of the human annexin V
Indication: Prevention of ischaemia/reperfusion injury associated with solid organ transplantation
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, 2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2012 Orphan designation EMA/OD/103/11 (2012)132 of 11/01/2012
05/02/2013 Change of name and/or address of sponsor
11/02/2014 Removal of orphan designation from Community Register